Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Genome-Wide Transcriptional Profiling and Structural Magnetic Resonance Imaging in the Maternal Immune Activation Model of Neurodevelopmental Disorders.
Cholinergic system and neuroinflammation: Implication in multiple sclerosis.
Circulating immune cells in multiple sclerosis.
[Improving the sexual quality of life of people with multiple sclerosis].
The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity.
Zika virus infection and Guillain-Barré syndrome: a review focused on clinical and electrophysiological subtypes.
In vitro and ex vivo models of multiple sclerosis.
Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.
Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
Probiotics Lactobacillus plantarum and bifidobacterium B94: cognitive function in demyelinated model.
Endocannabionoid System in Neurological Disorders.
Adipose-Derived Cells (Stromal Vascular Fraction) Transplanted for Orthopedical or Neurological Purposes: Are They Safe Enough?
Acute Disseminated Encephalomyelitis.
Pharmaceutical Approval Update.
Sex differences and subclinical retinal injury in pediatric-onset MS.
Multiple Autoantibodies and Neuromyelitis Optica Spectrum Disorders.
Therapeutic benefit of botulinum toxin A for the spasticity of the triceps surae in patients with multiple sclerosis: An observational study.
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study.
Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments.
A new dawn for genetic association studies in multiple sclerosis.
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.
Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment.
Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
Spasticity in multiple sclerosis and role of glatiramer acetate treatment.
Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.

Pages